Napa, CA (October 24, 2007) – Data from two Phase III clinical trials were presented today in Chicago at CHEST 2007, the annual scientific assembly of the American College of Chest Physicians (ACCP), ...
A phase 4 study of formoterol fumarate showed similar safety performance as placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, according to a recently published study.
Barcelona, September, 25 2014. - Almirall S.A. (ALM) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion ...
WILMINGTON, Del.--(BUSINESS WIRE)--Full results from the positive Phase III ETHOS trial showed AstraZeneca’s triple-combination therapy PT010 (budesonide ...
Asthma inhaler Patients with COPD who received a metered dose inhaler containing budesonide, glycopyrrolate, and formoterol fumarate showed lung function improvements through 52 weeks. This article is ...
The trial met its primary endpoint demonstrating that PT010 reduced the rate of moderate or severe COPD exacerbations by 24% compared with PT003 (rate ratio, 0.76; 95% confidence interval [CI], 0.69–0 ...
Review the side-effects of Mometasone Furoate and Formoterol Fumarate as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...
(Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO) SYMBICORT is a combination asthma medication that contains both an inhaled corticosteroid (ICS ...
Details concerning the Formoterol Fumarate combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...
Schering-Plough announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed and accepted for review by the FDA for the ...
Ritedose Pharmaceuticals, a division of The Ritedose Corporation, has secured Food and Drug Administration approval for formoterol fumarate inhalation solution (20 mcg/2 ml). “The approval further ...
DUBLIN--(BUSINESS WIRE)--The "Fumarate De Formoterol - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering. Fumarate De Formoterol Drug Insight, 2019 highlights the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results